產(chǎn)品名稱 | ATCC-BYS0110 Human [African American Male] Induced Pluripotent Stem (IPS) Cells |
---|---|
商品貨號(hào) | B242540 |
Organism | Homo sapiens, human |
Tissue | bone marrow CD34+ cells |
Cell Type | sendai virus reprogrammed hiPSC |
Product Format | frozen |
Biosafety Level | 2 [Cells contain Sendai viral DNA sequences] [It is the responsibility of the investigator to determine appropriate safety procedures for use with this material. As a reference, laboratory safety is discussed in the publication Biosafety in Microbiological and Biomedical Laboratories and can be accessed by searching "BMBL" at www.cdc.gov.] Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease | Normal |
Age | 33 |
Gender | Male |
Ethnicity | African American |
Storage Conditions | Liquid Nitrogen Vapor Phase (-130°C or colder) |
Karyotype | Normal karyotype, 46 XY |
Derivation | ATCC-BYS0110 Human Induced Pluripotent Stem Cells (iPSCs) were derived from bone marrow CD34+ cells obtained from a healthy African American male donor. |
Antigen Expression | SSEA4, Tra-1-60 (expressed on undifferentiated hiPSCs) >85%; SSEA1 (expressed on differentiated hiPSCs) < 15%. |
Complete Growth Medium | ATCC iPSCs have been adapted to feeder- and serum-free culture conditions. The base medium for this cell line is Pluripotent Stem Cell SFM XF/FF (ATCC® No. ACS-3002) which is a ready-to-use medium for serum-free and feeder-free iPSC culture. |
Subculturing | Cell culture dishes are coated with CellMatrix Basement Membrane Gel (ATCC® No. ACS-3035) to provide a surface for the attachment of iPSCs. Coating Procedure:
Dilute CellMatrix in DMEM:F12 to a working concentration of 150 μg/mL. For instance, if the protein concentration of CellMatrix (on certificate of analysis) is 14 mg/mL, then: (4 mL) x (0.15 mg/mL)/(14 mg/mL) = 0.043 mL. Therefore, add 43 μL CellMatrix directly in 4 mL cold DMEM: F-12 Medium Post thaw day 1, perform a 100% medium change and remove all cells that did not attach. Perform a 100% medium change every day. Passage the cells every 4 to 5 days (80% confluent) at an appropriate split ratio (a 1:4 split ratio is recommended). If the colonies are close to, or touching each other, the culture is overgrown. Overgrowth will result in differentiation. ROCK Inhibitor Y27632 is not necessary each time the culture medium is changed. It is required when cells are recovering from thaw on CellMatrix Gel-coated dishes containing 5 mL Pluripotent Stem Cell XF/FF medium/6-cm dish. This protocol is designed to passage stem cell colonies cultured in a 6 cm dish, using Stem Cell Dissociation Reagent (ATCC ACS-3010) to detach the cell colonies. The recommended spilt ratio is 1:4. Volumes should be adjusted according to the size and number of the tissue culture vessels to be processed. Reconstitution of Stem Cell Dissociation Reagent: Lyophilized proteins tend to be hygroscopic. Bring the vial of Stem Cell Dissociation Reagent to room temperature before opening. The vial should not be cool to the touch. Once opened, the lyophilized material should be stored desiccated. The specific activity of the reagent is found on the certificate of analysis. Dissolve the appropriate amount of Stem Cell Dissociation Reagent in DMEM: F-12 Medium to prepare a 0.5 U/mL working solution.
Note: Addition of ROCK inhibitor has been shown to increase the survival rate. The use of ROCK inhibitor may cause a transient spindle-like morphology effect on the cells. However, the colony morphology will recover after subsequent media change without ROCK inhibitor.
|
Cryopreservation | For optimal results, cryopreserve stem cell colonies when the cell cultures are 80%confluent. This protocol is designed to cryopreserve stem cell colonies cultured in a 6 cm dish.
|
Cells per Vial | ≥ 30 colonies after 5 days when seeded as directed |
STR Profile | Consistent with expected |
Sterility Tests | No growth after 21 days Mycoplasma - None Detected Zero Footprint Confirmation - None Detected |
Viral Testing |
Hepatitis B: Negative
HPV: Negative
HIV1: Negative
CMV: Negative
EBV: Negative
|
Functional Tests | Pluripotency Score >20, Novelty Score < 1.67 |
Name of Depositor | ATCC |
Year of Deposit | 2013 |
References | Lee CAA. Modeling and rescue of defective blood-brain barrier function of induced brain microvascularendothelial cells from childhood cerebral adrenoleukodystrophy patients. Fluids Barriers CNS 15(1):9, 2018. PubMed: 29615068 |
序號(hào) | 文章標(biāo)題 | 操作 |
---|---|---|
1 | ATCC細(xì)胞運(yùn)輸和處理 | 查看詳情 |
2 | 其他海外品牌代理 | 查看詳情 |
3 | ATCC代理 | 查看詳情 |
4 | 購(gòu)買須知 | 查看詳情 |
5 | 訂購(gòu)流程 | 查看詳情 |
梅經(jīng)理 | 17280875617 | 1438578920 |
胡經(jīng)理 | 13345964880 | 2438244627 |
周經(jīng)理 | 17757487661 | 1296385441 |
于經(jīng)理 | 18067160830 | 2088210172 |
沈經(jīng)理 | 19548299266 | 2662369050 |
李經(jīng)理 | 13626845108 | 972239479 |